MENU
PPH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS
VanEck Pharmaceutical ETF (PPH) Ownership - Who owns VanEck Pharmaceutical ETF?
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index... Show more
Category: #Health
Profile
Category
Health
Address
335 Madison Ave.19th FloorNew York
Phone
888-658-8287
Web
www.marketvectorsetfs.com
Details
Group
Domestic Stock Funds
Category
Health
Net Assets
519252540.00
Fund Existence
over 13 years
Turnover
12.00
Capitalization
N/A
Yield
2.35
Total Expense Ratio
0.36
Investment Style
N/A
Risk (Beta)
0.58
Fundamentals
PPH
Net Assets
519M
Yield
2.35
Fund Existence
over 13 years
Total Expense Ratio
0.36
Turnover
12.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
0.58
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.36
Assets in Top Ten Holdings
341M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
519M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.35
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
24.00
Number of Net Holdings
25.00
Number of Short Holdings
1.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
73.01%
Gain YTD
1.125
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Category Health
Profile
Fundamentals
Details
Category
Health
Address
335 Madison Ave.19th FloorNew York
Phone
888-658-8287
Web
www.marketvectorsetfs.com